The Technical AnalystExchange: HKSE Sector: Consumer products Industry: Drug Manufacturers—Specialty & Generic
Golden Throat Holdings Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.54% HKD3.69
America/New_York / 3 mai 2024 @ 03:50
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2 728.02 mill |
| EPS: | 0.510 |
| P/E: | 7.24 |
| Earnings Date: | Mar 28, 2024 |
| SharesOutstanding: | 739.30 mill |
| Avg Daily Volume: | 0.217 mill |
| RATING 2024-05-03 |
|---|
| A+ |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Buy | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/21 | 4/21 | 2/22 | 4/22 | 2/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.47x |
| Company: PE 7.24 | sector: PE 15.57 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.55x |
| Company: PE 7.24 | industry: PE 13.09 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
HKD6.00 (62.48%) HKD2.31 |
| Date: 2024-05-03 |
| Expected Trading Range (DAY) |
|---|
|
HKD 3.57 - 3.81 ( +/- 3.36%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | HKD3.69 (-0.54% ) |
| Volume | 0.0530 mill |
| Avg. Vol. | 0.217 mill |
| % of Avg. Vol | 24.40 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 6896.HK
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
6896.HK
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China. It offers Golden Throat lozenges over-the-counter medicine to relive symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat lozenge series products that include Dule lozenges and sugar-free Dule lozenges in various flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn; Yinxingye tablet, which is designed to facilitate blood circulation, remove blood stasis, and dredge energy channels; and herbal vegetable beverages for soothing voice and relieving sore throats. The company also exports its products to the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and Africa. Golden Throat Holdings Group Company Limited was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.